Left Atrial Appendage Occlusion: State of the Art

Chapter

Abstract

Percutaneous left atrial appendage occlusion (LAAO) is a new therapy for the prevention of systemic thromboembolism in patients with non-valvular atrial fibrillation. Currently, the most commonly used LAAO devices are the Watchman device (Boston Scientific, Natick, MA, USA) and the Amplatzer Amulet device (St Jude Medical, Plymouth, MN, USA). In this chapter, we describe the history and the most important clinical trials and registries related to LAAO, and some technical considerations, tips, and tricks around these devices. We also briefly cover some other newer LAAO devices. We discuss the challenges related to the anatomic variability of the left atrial appendage, pre- and periprocedural cardiac imaging, device sizing, and possible ways to prevent and manage complications.

References

  1. 1.
    Tzikas A, Sievert H, Holmes DR Jr. Percutaneous left atrial appendage occlusion in 2016. EuroIntervention. 2016;11(14):e1576–8.CrossRefGoogle Scholar
  2. 2.
    Sievert H, Lesh MD, Trepels T, Omran H, Bartorelli A, Della Bella P, Nakai T, Reisman M, DiMario C, Block P, Kramer P, Fleschenberg D, Krumsdorf U, Scherer D. Percutaneous left atrial appendage transcatheter occlusion to prevent stroke in high-risk patients with atrial fibrillation: early clinical experience. Circulation. 2002;105(16):1887–9.CrossRefGoogle Scholar
  3. 3.
    Sick PB, Schuler G, Hauptmann KE, Grube E, Yakubov S, Turi ZG, Mishkel G, Almany S, Holmes DR. Initial worldwide experience with the WATCHMAN left atrial appendage system for stroke prevention in atrial fibrillation. J Am Coll Cardiol. 2007;49:1490–5.CrossRefGoogle Scholar
  4. 4.
    Meier B, Palacios I, Windecker S, et al. Transcatheter left atrial appendage occlusion with Amplatzer devices to obviate anticoagulation in patients with atrial fibrillation. Catheter Cardiovasc Interv. 2003;60:417–22.CrossRefGoogle Scholar
  5. 5.
    Park JW, Bethencourt A, Sievert H, Santoro G, Meier B, Walsh K, Lopez-Minguez JR, Meerkin D, Valdés M, Ormerod O, Leithäuser B. Left atrial appendage closure with Amplatzer Cardiac Plug in atrial fibrillation: initial European experience. Catheter Cardiovasc Interv. 2011;77:700–6.CrossRefGoogle Scholar
  6. 6.
    Holmes DR, Reddy VY, Turi ZG, et al. Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fi brillation: a randomised noninferiority trial. Lancet. 2009;374:534–42.CrossRefGoogle Scholar
  7. 7.
    Holmes DR Jr, Kar S, Price MJ, Whisenant B, Sievert H, Doshi SK, Huber K, Reddy VY. Prospective randomized evaluation of the Watchman left atrial appendage closure device in patients with atrial fibrillation versus long-term warfarin therapy: the PREVAIL trial. J Am Coll Cardiol. 2014;64(1):1–12.CrossRefGoogle Scholar
  8. 8.
    Tzikas A, Shakir S, Gafoor S, Omran H, Berti S, Santoro G, Kefer J, Landmesser U, Nielsen-Kudsk JE, Cruz-Gonzalez I, Sievert H, Tichelbäcker T, Kanagaratnam P, Nietlispach F, Aminian A, Kasch F, Freixa X, Danna P, Rezzaghi M, Vermeersch P, Stock F, Stolcova M, Costa M, Ibrahim R, Schillinger W, Meier B, Park JW. Left atrial appendage occlusion for stroke prevention in atrial fibrillation: multicentre experience with the AMPLATZER Cardiac Plug. EuroIntervention. 2016;11:1170–9.CrossRefGoogle Scholar
  9. 9.
    Holmes DR Jr, Doshi SK, Kar S, et al. Left atrial appendage closure as an alternative to warfarin for stroke prevention in atrial fibrillation – a patient-level meta-analysis. J Am Coll Cardiol. 2015;65:2614–23.CrossRefGoogle Scholar
  10. 10.
    Reddy VY, Mobius-Winkler S, Miller MA, et al. Left atrial appendage closure with the Watchman device in patients with a contraindication for oral anticoagulation: the ASAP study (ASA Plavix feasibility study with Watchman left atrial appendage closure technology). J Am Coll Cardiol. 2013;61:2551–6.CrossRefGoogle Scholar
  11. 11.
    Boersma LV, Schmidt B, Betts TR, Sievert H, Tamburino C, Teiger E, Pokushalov E, Kische S, Schmitz T, Stein KM, Bergmann MW, investigators E. Implant success and safety of left atrial appendage closure with the WATCHMAN device: peri-procedural outcomes from the EWOLUTION registry. Eur Heart J. 2016;37(31):2465–74.CrossRefGoogle Scholar
  12. 12.
    Reddy VY, Gibson DN, Kar S, O’Neill W, Doshi SK, Horton RP, Buchbinder M, Gordon NT, Holmes DR. Post-FDA approval, initial US clinical experience with Watchman left atrial appendage closure for stroke prevention in atrial fibrillation. J Am Coll Cardiol. 2016. pii: S0735–1097(16)36641–4.  https://doi.org/10.1016/j.jacc.2016.10.010. [Epub ahead of print].
  13. 13.
    Blackshear JL, Odell JA. Appendage obliteration to reduce stroke in cardiac surgical patients with atrial fibrillation. Ann Thorac Surg. 1996;61:755–9.CrossRefGoogle Scholar
  14. 14.
    Granger CB, Alexander JH, McMurray JJ, Lopes RD, Hylek EM, Hanna M, Al-Khalidi HR, Ansell J, Atar D, Avezum A, Bahit MC, Diaz R, Easton JD, Ezekowitz JA, Flaker G, Garcia D, Geraldes M, Gersh BJ, Golitsyn S, Goto S, Hermosillo AG, Hohnloser SH, Horowitz J, Mohan P, Jansky P, Lewis BS, Lopez-Sendon JL, Pais P, Parkhomenko A, Verheugt FW, Zhu J, Wallentin L. Apixaban versus warfarin in patients with atrial fi brillation. N Engl J Med. 2011;365:981–92.CrossRefGoogle Scholar
  15. 15.
    Patel MR, Mahaffey KW, Garg J, Pan G, Singer DE, Hacke W, Breithardt G, Halperin JL, Hankey GJ, Piccini JP, Becker RC, Nessel CC, Paolini JF, Berkowitz SD, Fox KA, Califf RM. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med. 2011;365:883–91.CrossRefGoogle Scholar
  16. 16.
    Kefer J, Tzikas A, Freixa X, Shakir S, Gafoor S, Nielsen-Kudsk JE, Berti S, Santoro G, Aminian A, Landmesser U, Nietlispach F, Ibrahim R, Danna PL, Benit E, Budts W, Stammen F, De Potter T, Tichelbäcker T, Gloekler S, Kanagaratnam P, Costa M, Cruz-Gonzalez I, Sievert H, Schillinger W, Park JW, Meier B, Omran H. Impact of chronic kidney disease on left atrial appendage occlusion for stroke prevention in patients with atrial fibrillation. Int J Cardiol. 2016;207:335–40.CrossRefGoogle Scholar
  17. 17.
    Freixa X, Gafoor S, Regueiro A, Cruz-Gonzalez I, Shakir S, Omran H, Berti S, Santoro G, Kefer J, Landmesser U, Nielsen-Kudsk JE, Sievert H, Kanagaratnam P, Nietlispach F, Gloekler S, Aminian A, Danna P, Rezzaghi M, Stock F, Stolcova M, Costa M, Ibrahim R, Schillinger W, Park JW, Meier B, Tzikas A. Comparison of efficacy and safety of left atrial appendage occlusion in patients aged <75 to ≥75 years. Am J Cardiol. 2016;117:84–90.CrossRefGoogle Scholar
  18. 18.
    Saw J, Tzikas A, Shakir S, Gafoor S, Omran H, Nielsen-Kudsk J, Kefer J, Aminian A, Berti S, Santoro G, Nietlispach F, Moschovitis A, Cruz-Gonzalez I, Stammen F, Tichelbacker T, Freixa X, Ibrahim R, Schillinger W, Meier B, Sievert H, Gloekler S. Incidence and clinical impact of device-associated thrombus and peri-device leak following LAA closure with the Amplatzer Cardiac Plug. J Am Coll Cardiol Intv. 2017;10(4):391–9.CrossRefGoogle Scholar
  19. 19.
    Kirchhof P, Benussi S, Kotecha D, Ahlsson A, Atar D, Casadei B, Castella M, Diener HC, Heidbuchel H, Hendriks J, Hindricks G, Manolis AS, Oldgren J, Popescu BA, Schotten U, Van Putte B, Vardas P, Agewall S, Camm J, Baron Esquivias G, Budts W, Carerj S, Casselman F, Coca A, De Caterina R, Deftereos S, Dobrev D, Ferro JM, Filippatos G, Fitzsimons D, Gorenek B, Guenoun M, Hohnloser SH, Kolh P, Lip GY, Manolis A, McMurray J, Ponikowski P, Rosenhek R, Ruschitzka F, Savelieva I, Sharma S, Suwalski P, Tamargo JL, Taylor CJ, Van Gelder IC, Voors AA, Windecker S, Zamorano JL, Zeppenfeld K. 2016 ESC guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J. 2016;37(38):2893–962.CrossRefGoogle Scholar
  20. 20.
    Tzikas A, Bergmann MW. Left atrial appendage closure: patient, device and post-procedure drug selection. EuroIntervention. 2016;12(Suppl X):X48–54.CrossRefGoogle Scholar
  21. 21.
    Tzikas A, Holmes DR, Gafoor S, Ruiz CE, Blomström-Lundqvist C, Diener HC, Cappato R, Kar S, Lee RJ, Byrne RA, Ibrahim R, Lakkireddy D, Soliman OI, Nabauer M, Schneider S, Brachman J, Saver JL, Tiemann K, Sievert H, Camm J, Lewalter T. Percutaneous left atrial appendage occlusion: the Munich consensus document on definitions, endpoints and data collection requirements for clinical studies. EuroIntervention. 2016;12(1):103–11.CrossRefGoogle Scholar
  22. 22.
    Veinot JP, Harrity PJ, Gentile F, Khandheria BK, Bailey KR, Eickholt JT, Seward JB, Tajik AJ, Edwards WD. Anatomy of the normal left atrial appendage: a quantitative study of age-related changes in 500 autopsy hearts: implications for echocardiographic examination. Circulation. 1997;96:3112–5.CrossRefGoogle Scholar
  23. 23.
    Di Biase L, Santangeli P, Anselmino M, Mohanty P, Salvetti I, Gili S, Horton R, Sanchez JE, Bai R, Mohanty S, Pump A, Cereceda Brantes M, Gallinghouse GJ, Burkhardt JD, Cesarani F, Scaglione M, Natale A, Gaita F. Does the left atrial appendage morphology correlate with the risk of stroke in patients with atrial fibrillation? Results from a multicenter study. J Am Coll Cardiol. 2012;60:531–8.CrossRefGoogle Scholar
  24. 24.
    Freixa X, Tzikas A, Basmadjian A, Garceau P, Ibrahim R. The chicken-wing morphology: an anatomical challenge for left atrial appendage occlusion. J Interv Cardiol. 2013;5:509–14.CrossRefGoogle Scholar
  25. 25.
    Tzikas A, Gafoor S, Meerkin D, Freixa X, Cruz-Gonzalez I, Lewalter T, Saw J, Berti S, Nielsen-Kudsk JE, Ibrahim R, Lakkireddy D, Paul V, Arzamendi D, Nietlispach F, Worthley SG, Hildick-Smith D, Thambo JB, Tondo C, Aminian A, Kalarus Z, Schmidt B, Sondergaard L, Kefer J, Meier B, Park JW, Sievert H, Omran H. Left atrial appendage occlusion with the AMPLATZER Amulet device: an expert consensus step-by-step approach. EuroIntervention. 2016;11:1512–21.CrossRefGoogle Scholar
  26. 26.
    Al-Kassou B, Tzikas A, Stock F, Neikes F, Völz A, Omran H. A comparison of two-dimensional and real time 3D transesophageal echocardiography and angiography for assessing the left atrial appendage anatomy for sizing a left atrial appendage occlusion system – impact of volume loading. EuroIntervention. 2016. pii: EIJ-D-15-00543.  https://doi.org/10.4244/EIJ-D-15-00543.
  27. 27.
    Berti S, Paradossi U, Meucci F, Trianni G, Tzikas A, Rezzaghi M, Stolkova M, Palmieri C, Mori F, Santoro G. Reply: intracardiac echocardiographic imaging of the left atrial appendage and detection of a peridevice leak after device occlusion. JACC Cardiovasc Interv. 2015;8(1 Pt A):126–7.  https://doi.org/10.1016/j.jcin.2014.12.001.CrossRefPubMedGoogle Scholar
  28. 28.
    Bergmann MW, Landmesser U. Left atrial appendage closure for stroke prevention in non-valvular atrial fibrillation: rationale, devices in clinical development and insights into implantation techniques. EuroIntervention. 2014;10(4):497–504.CrossRefGoogle Scholar
  29. 29.
    Bellmann B, Schnupp S, Kühnlein P, Javernik C, Kleinecke C, Rillig A, Landmesser U, Brachmann J, Park JW. Left atrial appendage closure with the new Occlutech® device: first in man experience and neurological outcome. J Cardiovasc Electrophysiol. 2016. doi:  https://doi.org/10.1111/jce.13141. [Epub ahead of print].CrossRefPubMedGoogle Scholar
  30. 30.
    Lam YY. A new left atrial appendage occluder (Lifetech LAmbre device) for stroke preventionin atrial fi brillation. Cardiovasc Revasc Med. 2013;14:134–6.CrossRefGoogle Scholar
  31. 31.
    Bartus K, Han F, Bednarek J, Myc J, Kapelak B, Sadowski J, Lelakowski J, Bartus S, Yakubov S, Lee R. Percutaneous left atrial appendage suture ligation using the LARIAT device in patients with atrial fibrillation: initial clinical experience. J Am Coll Cardiol. 2013;62:108–18.CrossRefGoogle Scholar
  32. 32.
    Aminian A, Lalmand J, Tzikas A, Budts W, Benit E, Kefer J. Embolization of left atrial appendage closure devices: a systematic review of cases reported with the Watchman device and the Amplatzer Cardiac Plug. Catheter Cardiovasc Interv. 2015;86:128–35.CrossRefGoogle Scholar
  33. 33.
    Viles-Gonzales J, Kar S, Douglas P, Dukkipati S, Fledman T, Horton R, Holmes D, Reddy V. The clinical impact of incomplete left atrial appendage closure with the Watchman device in patients with atrial fibrillation. J Am Coll Cardiol. 2012;59:923–9.CrossRefGoogle Scholar
  34. 34.
    Fassini G, Conti S, Moltrasio M, Maltagliati A, Tundo F, Riva S, Dello Russo A, Casella M, Majocchi B, Zucchetti M, Russo E, Marino V, Pepi M, Tondo C. Concomitant cryoballoon ablation and percutaneous closure of left atrial appendage in patients with atrial fibrillation. Europace. 2016;18(11):1705–10.CrossRefGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  1. 1.AHEPA University Hospital of Thessaloniki, Aristotle University of ThessalonikiThessalonikiGreece

Personalised recommendations